Center for Cell and Organ Biotechnology Hosts Enlightening Scientific Symposium
COLLEGE STATION, TX, JULY 21 – Last Friday, a panel of Center
for Cell and Organ Biotechnology (CCOB) participants convened for a
one-day scientific symposium at the Texas A&M Institute of
Preclinical Studies. Topics ranged from Texas Heart Institute’s
molecular cardiology research programs and clinical studies in stem
cell therapy to commercialization strategies for early stage
The CCOB, supported by Texas Emerging Technology Fund, is a new
collaboration between the Texas A&M College of Veterinary
Medicine & Biomedical Sciences (CVM) in College Station and
Texas Heart Institute (THI) in Houston. Led by Dr. Doris Taylor,
director of the CCOB and director of Regenerative Medicine Research
at THI, the center includes scientists, engineers, physicians,
veterinarians, and business managers from both organizations and
other colleges located at Texas A&M University.
“It was exciting to be together in College Station with
representatives of all aspects of the CCOB including the Oversight
Board, the External Commercialization Advisory Group (ECAG), and
CCOB participants,” Taylor said. “This was a chance for all invited
to share their knowledge and formulate new ideas for potential
collaborations leading to commercialization.”
Presenters at the symposium included Taylor, members of the CCOB
Oversight Board, Dr. Eleanor Green, dean of the College of
Veterinary Medicine & Biomedical Sciences, and Dr. James T.
Willerson, president and medical director of THI.
“With this symposium, our goal was to educate each other about
facilities available to the CCOB at both institutions,” Taylor
continued. “We strove to empower our faculty to innovate, translate
those innovations for patient benefit, and train the next
generation of scientists and innovators.”
Taylor draws from expertise at both institutions to position the
CCOB as a world leader in adult stem cell research, organ
transplantation, and personalized medicine. Launched in 2013, the
CCOB has grown considerably by recruiting distinguished scientists
from out of state to both Texas A&M and THI, as well as life
sciences industry executives to provide input on the ECAG.
“True to the Texas Emerging Technology Fund mission for a
research superiority award, research talent abounds within the
CCOB,” Green said. “With two world-class organizations, the Texas
Heart Institute and the Texas A&M College of Veterinary
Medicine & Biomedical Sciences, joining forces, the CCOB is
destined to make a difference for human patients, animal patients,
and the world they share by building the medicines of
For more information about the Center for Cell and Organ
Biotechnology, please visit our website at www.ccobtexas.org.
For more information about the Texas A&M CVM, please visit
our website at vetmed.tamu.edu or join us on Facebook.
For more information, contact:
Dr. Megan Palsa